Skip to content

Evaluation of a Probiotic On Anxiety and Stress in Healthy Adults Sensible to Daily Stress

Evaluation Des Effets Anti-Stress D'un Probiotique Nomme PROBIOSTICK® Sur Des Sujets Humains Volontaires Sains Sensibles Au Stress De La Vie Quotidienne

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00807157
Acronym
BIOSTRESS
Enrollment
66
Registered
2008-12-11
Start date
2008-12-31
Completion date
2009-04-30
Last updated
2009-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Stress

Keywords

PROBIOSTICK®, Probiotic, Anxiety, Daily stress

Brief summary

The purpose of the the study is to determine if PROBIOSTICK® decrease stress and anxiety of people sensible to daily stress.

Interventions

DIETARY_SUPPLEMENTPROBIOSTICK® during 30 days

Every morning subjects will consume a stick of PROBIOSTICK® during 30 days

DIETARY_SUPPLEMENTPlacebo during 30 days

Every morning subjects will consume a stick of placebo during 30 days

Sponsors

Institut Rosell Lallemand
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Caucasian healthy men or women * Age 30-60 years * Hospital anxiety and depression score equal or below 12 and above 4 * Standard safety biology

Exclusion criteria

* HAD A results above 12 and below 4 * HAD D results above 12 * Neurologic or psychiatric pathology * Consumption of psychotropic * High level of caffeine consumption * Any important chronic pathology * Drugs wich impairs concentration, anxiety and stress

Design outcomes

Primary

MeasureTime frame
SCL 90 questionnaireday 0 and day 30

Secondary

MeasureTime frame
Stress perçu, coping de vitaliano, hospital anxiety and depression questionnaires and urinary cortisol measurementday-14 ; day 0 and day 30

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026